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Pten is a multifunctional tumor suppressor. Deletions and mutations in the Pten gene have been asso-
ciated with multiple forms of human cancers. Pten is a central regulator of several signaling pathways
that inﬂuences multiple cellular functions. One such function is in cell motility and migration, although
the precise mechanism remains unknown. In this study, we deleted Pten in the embryonic lung epi-
thelium using Gata5-cre mice. Absence of Pten blocked branching morphogenesis and ERK and AKT
phosphorylation at E12.5. In an explant model, PtenΔ/Δ mesenchyme-free embryonic lung endoderm
failed to branch. Inhibition of budding in PtenΔ/Δ explants was associated with major changes in cell
migration, while cell proliferation was not affected. We further examined the role of ERK and AKT in
branching morphogenesis by conditional, endodermal-speciﬁc mutants which blocked ERK or AKT
phosphorylation. MEKDM/þ ; Gata5-cre (blocking of ERK phosphorylation) lung showed more severe
phenotype in branching morphogenesis. The inhibition of budding was also associated with disruption of
cell migration. Thus, the mechanisms by which Pten is required for early endodermal morphogenesis
may involve ERK, but not AKT, mediated cell migration.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
The mammalian lung is a highly precise branched structure
consisting of epithelial airways and alveoli as well as mesenchymal
stroma and vascular networks. Each of the latter components is
essential to proper respiratory functions. The formation of the
lungs involves the structuring of epithelial tissues into complex
but highly organized tubular networks that transport gases. This
process is generally referred to as “branching morphogenesis”. In
mammalian lung, branching morphogenesis starts from formation
of an anlagen and invagination of the epithelium to branch in-
itiation and outgrowth. The branching pattern is controlled ge-
netically and gives rise to successive rounds of branched structures
in a predictable manner.
The formation of lung via branching morphogenesis can gen-
erally be subdivided into a series of steps: formation of anlagen;
formation of primary bud; branch initiation; branch outgrowth;
organization of successive branching events and differentiation of
proximal–distal structures. To generate this arborized epithelial
network, each individual step depends on proper execution of cell, Life Science Building, Room
R China.proliferation, migration, apoptosis and changes in cell shape. The
pattern of arborization depends on positive regulation by growth
factors and receptors to promote proliferation and migration and
negative regulation to inhibit excessive budding and bifurcation.
How potential positive and negative signals are integrated to
control cell movement, while retaining the essential character of
an invasive epithelium, remains unclear.
A sequence of induction of factors was found. The implication
of these factors in lung development was based on their associa-
tion with speciﬁc lung defects in knockout mouse models. The
major factors found regulating the branching are Fibroblast
Growth Factors (FGFs), Transforming Growth Factor-β (TGF-β)
superfamily, Wnt and Sonic Hedgehog. Recently Pten has been
identiﬁed to control lung morphogenesis (Yanagi et al., 2007).
PTEN has a dual speciﬁcity protein phosphatase and lipid phos-
phatase activity that can dephosphorylate serine, threonine and
tyrosine residues. This positions PTEN as a critical negative reg-
ulator of PI3K/AKT signaling pathway (Vivanco and Sawyers,
2002). Deletion of Pten in mouse models revealed that PTEN is
critical for animal development. Pten null embryos die early dur-
ing embryogenesis (Di Cristofano et al., 1998). Thus, much of our
current knowledge regarding the roles of PTEN in development is
acquired from animals with tissue-speciﬁc Pten deletion using the
Cre–LoxP system. The functions of PTEN in individual tissues in-
clude stem cell self-renewal and proliferation, cell differentiation
Y. Xing et al. / Developmental Biology 408 (2015) 56–65 57and migration, organ size control, and the hormone-regulated
organogenesis (Stiles et al., 2004).
The mitrogen-activated protein kinase (MAPK) /extracellular
signal-regulated kinase (ERK) cascade is conserved in mammals
and controls early developmental processes, including determi-
nation of morphology, organogenesis, synaptic plasticity and
growth (McKay and Morrison, 2007). Signal transmission via this
cascade is initiated by the activation of cell surface receptors by
extracellular ligands, which results in the phosphorylation and
activation of the MAPK/ERK kinases. Activation of the MAPK/ERK
pathway leads to transcriptional control of genes important for cell
proliferation and differentiation (Sanges and Cosma, 2010). Evi-
dence is provided that MAPK/ERK kinases inﬂuence the cells’
motility machinery. Inhibition of ERK activity causes decreased cell
migration on extracellular matrix protein (Klemke et al., 1997).
In the current study, we assessed the direct impact of epithelial
Pten inactivation on lung morphogenesis. The results demonstrate
that Pten controls early stage branching morphogenesis by reg-
ulating epithelial cell migration, without major or measurable
changes in cell proliferation. This function is mediated via phos-
phorylation of ERK, which is also essential for embryonic lung
epithelial cell migration.2. Materials and methods
2.1. Mouse lines
PtenΔ/Δmice were generated by crossing Ptenﬂ/ﬂ (Xing et al.,
2008) with Gata5-Cre (Xing et al., 2010) mice.MEKDN/þ , R26StopFL-
Pik3ca and mT/mG mice were purchased from The Jackson La-
boratory. MEKDN/þ; Gata5-Cre and R26StopFL-Pik3ca; Gata5-Cre
mice were generated by crossing MEKDN/þ and R26StopFL-Pik3ca
with Gata5-Cre mice.
2.2. Lung culture and lung endodermal explant culture
Whole embryonic lungs were dissected at gestational stage
E11.5. In each Grobstein Falcon dish, two to three lungs were
placed on ﬁlters (Millipore, Bedford, MA) that were placed on top
of a stainless steel grid. The ﬁlters were in close contact with BGJb
(GIBCO, Carlsbad, CA) growth medium supplemented with peni-
cillin (100 U/ml) and streptomycin (100 μg/ml), with 20 μM MEK
inhibitor U0126 (Promega, Madison, WI) or same amount of DMSO
as control. Heparin beads (Sigma) were incubated with FGF10
(10 μl of a 50 ng/μl solution; R&D Systems, MN) at 37 °C for 2hr,
grafted onto lung explants and cultured for 48 h. The lungs were
incubated under optimal humidity in 95% air/5% CO2. At indicated
times, the lung explants were either homogenized in Trizol (GIB-
CO) for RNA isolation or ﬁxed in 4% Paraformaldehyde (PFA).
For mesenchyme-free endodremal lung explant culture, distal
lung tips were isolated as previously described (Bellusci et al.,
1997). Brieﬂy, lungs from mutant or control embryos were dis-
sected at E13.5 and treated with Dispase (50 U/ml, BD Biosciences,
Franklin Lakes, NJ) at 4 °C for 20 min. Epithelial buds of distal lung
tips were then isolated by removing mesenchyme with tungsten
needles and embedded into growth factor-reduced Matrigel
(Fisher Scientiﬁc, Fremont, CA), diluted 1:1 in culture medium
(50% DMEM: 50% Ham's F12, 0.05 U/ml penicillin, 0.05 mg/ml
streptomycin). After polymerization of the Matrigel at 37 °C, ex-
plants were covered with culture medium with FGF10 and cul-
tured at 37 °C at 5% CO2 for various lengths of time as indicated.
FGF10-saturated beads were prepared with acrylic beads with
immobilized heparin (Sigma). Beads were rinsed with PBS three
times, manually selected under dissection microscope and then
soaked in 50ng/μl recombinant human FGF10 at 37 °C for 1hr. Thebeads were then washed in DMEM medium for 1hr at 37 °C before
use (Li et al., 2005). MEK inhibitor U0126 was purchased from
Promega.
2.3. Migration assay
Mesenchyme-free explants were treated with 0.25% trypsin/
EDTA and DNase I(1:1) at 37 °C for 15 min. E18.5 lung epithelial
cells were isolated according to Corti et al. (1996). The lungs were
carefully chopped into pieces and treated with dispase at 37 °C for
15 min. DMEM was added to terminate the reaction. The cell
suspension was ﬁltered through 100 μm, 40 μm and 20 μm ﬁlters.
Then the epithelial cells were plated on culture dish (BD
Bioscience) and culture in DMEM and 10% FBS at 37 °C. Cell
monolayers were wounded with a plastic tip. Cell migration was
followed for 6hr at 37 °C and photographed.
2.4. Proliferation assay
Subsequent to culturing, endodermal explants were treated
with bromodeoxyuridine (BrdU) reagent at 1 μl per 400 μl med-
ium for 3 h. The explants were ﬁxed, dehydrated and parafﬁn
embedded. The sections were then re-hydrated and labeled by
BrdU staining kit (Invitrogen, Carlsdad, CA) and Hematoxylin/Eosin
staining. The sections were then photographed. The BrdU positive
cells as well as the total number of cells (Hematoxylin/Eosin po-
sitive cells) in the explants per section were counted manually
using photomicrograph of tissue taken at 40 on a Zeiss Micro-
scope. The percent of labeled cells was calculated.
2.5. Cell death analysis
The cultured endodermal explants were ﬁxed, dehydrated and
embedded in parafﬁn and 5 μm sections were prepared. The “In
Situ Cell Death Detection Kit, Fluoresein” kit (Roche Allied Science,
Indianapolis, IN) was used for detection and quantiﬁcation of cell
apoptosis at single cell level, based on labeling of DNA strand
breaks (TUNEL technology). The sizes of labeled areas and whole
sections were calculated for the percentage of cell death. 5 sec-
tions from each treatment were analyzed.
2.6. Immunohistochemistry
5 μm tissue sections were prepared. Subsequent to depar-
afﬁnization, the sections were hydrated, heated in 10 mM citrate
buffer (pH6.0) and treated with 10% H2O2 in methanol for 20 min
and blocked with 10% of nonimmune serum. Sections were then
incubated with primary antibodies at 4 °C overnight. Biotinylated
secondary antibody and streptavidin-peroxidase conjugate (Vector
Laboratories, Inc.) were used to detect the bound antibodies. The
sections were developed with diaminobenzidine. GFP and Ki67
primary antibody was purchased from Thermo Scientiﬁc.
2.7. RNA extraction and Real-time PCR
Total RNA was isolated from lungs or endodermal explants
using Trizol (GIBCO). The cDNA was synthesized from 1 μg total
RNA by following the protocol of the SuperScriptTM First-Strand
Synthesis Kit (Invitrogen). Real-time PCR was performed by a
LightCycler System (Roche). Primer sets for following genes were
used for Real-time PCR: Cdc42: 5′-TGCTCTGCCCTCACACAG-3′
and 5′-GGCTCTTCTTCGGTTCTGG-3′; Rac1: 5′-AGATGCAGGCCAT-
CAATGT-3′ and 5′-GAGCAGGCAGGTTTTACCAA-3′; RhoA: 5′-GAAT-
GACGAGCACACGAGAC-3′ and 5′-TCCTGTTTGCCATATCTCTGC-3′.
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Cells or lung tissues were harvested and frozen in liquid ni-
trogen. Protein extracts were prepared in RIPA buffer (Sigma, St.
Louis, MO) by homogenization, and equal amounts of protein were
separated on 4–12% NuPAGE gels (Invitrogen, Carlsbad, CA). Pro-
teins were transferred onto Immobilon-P transfer membranes
(Millipore Corp. Billerica, MA) and analyzed by western blotting
using antibodies recognizing the following proteins: ERKP, ERK,
AKTP, Pten and PI3 Kinase p110 (Cell Signaling Technology,
Danvers, MA), and α-tubulin (BioGenex, San Ramon, CA).3. Results
3.1. Epithelial-speciﬁc deletion of Pten in the murine lung
To determine the potential role of epithelial Pten signaling in
lung morphogenesis, we used a Gata5-Cre mouse line (Xing et al.,
2010) to generate Pten deletion in the lung epithelium (Fig. 1,
Panel A). The pattern, efﬁciency and cell type speciﬁcity of the
Gata5-Cre mouse line in mediating LoxP-dependent DNA excision
in the lung was determined by crossing with mT/mG reporter mice
(Fig. 1, Panel B). mT/mG mice possess LoxP sites on either side of a
membrane-targeted tdTomato (mT) cassette and express strong red
ﬂuorescence in all tissues and cell types. When bred to Cre re-
combinase expressing mice, the resulting offspring have the mT
cassette deleted in the Cre expressing tissue(s), allowing expres-
sion of the membrane-targeted EGFP (mG) cassette located just
downstream. In E13.5 Gata5-Cre; mT/mG double transgenic em-
bryos, EGFP activity was found to be uniform and limited to the
endodermally derived lung epithelium (Fig. 1, Panel B, a and b).
Immuno-histochemistry (IHC) with an anti-GFP antibody showed
similar epithelial cell type speciﬁcity (Fig. 1, Panel B, c and d). To
test the efﬁciency of Pten deletion in PtenΔ/Δ lung, we measured
the mRNA level of Pten by real-time PCR and expression of Pten by
IHC in E18.5 lung. The results showed that the ablation of Pten
caused signiﬁcant decrease of Pten (Supplemental Fig. 2).
Inactivation of Pten in mice, referred to simply as PtenΔ/Δ,Fig. 1. Generation of PtenΔ/Δ; Gata5-cre mice. Panel A: PtenΔ/Δ; Gata5-Cre was generated b
in E12.5 lung was analyzed by GFP labeling in Gata5-Cre; mT/mG lung (a and b). Anti-G
Gata5-Cre lung appeared smaller in size and less branching (Panel C). On E18.5, there was
C, f and h).caused abnormal branching of the endoderm in the lung of E12.5
embryos (Fig. 1, Panel C, e–h). Compared with the controls, the
PtenΔ/Δ lungs were consistently smaller in overall size and con-
tained fewer branches (Fig. 1, Panel C, e and g). However, as de-
velopment proceeds there appeared to be compensation for these
early defects. By E18.5 the lungs were indistinguishable from the
control (Fig. 1, Panel C, f and h). And, the newborn PtenΔ/Δmice did
not appear to have difﬁculty breathing (data not shown).
3.2. Pten is required for cell migration in early lung
To analyze the impact of Pten on endodermal branching, we
examined the response of lung mesenchyme-free endoderm to
FGF10. Mesenchyme-free nascent endodermal tissue can be iso-
lated from mouse embryonic lungs of E12.5 gestation and ex-
planted in Matrigel for various studies (Xing et al., 2008). Culturing
of endodermal explants requires the presence of FGF10, which is
necessary and sufﬁcient to direct branching morphogenesis (Bel-
lusci et al., 1997). In the following studies, all control and PtenΔ/Δ
explant culture contained 400 ng/ml of FGF10 ligand for survival
and induction of branching morphogenesis as described pre-
viously (Xing et al., 2008). Fig. 2 shows the results of these studies
at times 0 and 48 hours. As expected, FGF10 had a robust impact
on induction of branching morphogenesis in E12.5 control lung
endoderm (Fig. 2, Panel A, a and c). Without exception, inactiva-
tion of Pten in PtenΔ/Δ explants strongly inhibited FGF10-induced
branching (Fig. 2, Panel A, b and d).
Lung branching morphogenesis requires cell proliferation and
migration. To examine whether inhibition of FGF10-induced en-
dodermal branching morphogenesis observed in PtenΔ/Δ explants
is accompanied by changes in cellular proliferation, we used the
BrdU labeling approach. The ratio of BrdU positive cells as a frac-
tion of total cells was determined by manual counting of multiple
samples. The analysis showed no signiﬁcant differences in cellular
proliferation between control and PtenΔ/Δ explants (Fig. 2, Panel
B).
To address whether inactivation of Pten affected cell migration,
we cultured the endodermal explants with directional FGF10 sig-
naling. The control and PtenΔ/Δ explants were placed 215–260 μmy crossing Ptenﬂ/ﬂwith Gata5-Cre mice. Panel B: Gata5-Cre-mediated recombination
FP antibody showed speciﬁc staining in epithelial cells (c and d). On E12.5, PtenΔ/Δ;
no difference in branching morphogenesis between mutant and control lung (Panel
Fig. 2. Deletion of Pten affects endodermal morphogenesis by inhibiting cell migration. Isolated endodermal explants from E12.5 mouse embryos were cultured in presence
of FGF10. In PtenΔ/Δ explant, FGF10-induced branching morphogenesis is blocked (Panel A). No signiﬁcant difference was observed in the ratio of BrdU positive cells (in total
cells) between the control and PtenΔ/Δ explants. P¼0.84 (Panel B). Endodermal explants from both PtenΔ/Δ and control lungs are treated with FGF10-soaked beads. The control
explants move towards FGF10 source after 10 h. In opposite, PtenΔ/Δ explants show no sign of movement (Panel C). Cells isolated from endodermal explants were cultured
and scratched to create a wound. The migration of the cells was photography at 0 h and 6 h after wounding (Panel D). The percentage of wound healing was calculated from
the mean of 20 wound widths per condition with SD measured at 6 h (Panel E). By real-time PCR analysis, the expression of RhoA, Rac1 and Cdc42 is reduced largely in E12.5
PtenΔ/Δ lungs (Panel F). In contrast, the epithelium cells from E18.5 PtenΔ/Δ lung showed no difference in cell migration vs control (Panel G&H). The expression pattern of
RhoA, Rac1 and Cdc42 in E18.5 PtenΔ/Δ lung is opposite from E12.5 (Panel I).
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chemotaxis in the direction of the FGF10 beads as early as ap-
proximately 10 hours of culturing. Within the same distance from
FGF10 signaling source, the PtenΔ/Δ explants showed no evidence
of chemotaxis (Fig. 2, Panel C). We also isolated and cultured the
epithelial cells from mesenchyme-free explants. The monolayer of
epithelial cells from control or PtenΔ/Δ explants was injured by a
pipette tip, and cell migration to close the wound was analyzed.
After 6 hours, cells from control explants had undergone a 63%
wound closure. In contrast, cells from PtenΔ/Δ explants showed a
mere 36% wound closure (Fig. 2, Panel D and E). This observation
indicated that Pten is required for cell migration. Rho family
GTPases, particularly RhoA, Rac1 and Cdc42, are key regulators of
cell polarization and directional migration (Iden and Collard,
2008). Recent data proposed that RhoA functions as an initi-
ator of membrane protrusion by promoting actin polymerization,
whereas Rac1 and Cdc42 might actually facilitate protrusion by
regulating cell adhesion (Machacek et al., 2009). Consistent with
our earlier result, quantitative PCR analysis showed signiﬁcantly
decreased expression of RhoA, Rac1 and Cdc42 in E12.5 PtenΔ/Δ
lung, when compared to controls (Fig. 2, Panel F).
To compare with the early stages of lung development, we also
analyzed migration of cell extracted from E18.5 lungs. No differ-
ences were observed in isolated epithelial cell monolayers from
control or PtenΔ/Δ lungs. Both exhibited 52–53% wound closer
within a 12 hour period, suggesting similar abilities in cell mi-
gration between the control and the PtenΔ/Δ lung cells (Fig. 2,
Panel G and H). Also, in contrast to E12.5 lungs, the expression of
RhoA, Rac1 and Cdc42 was increased in E18.5 PtenΔ/Δ lungs as
compared to that of control lungs (Fig. 2, Panel I).
3.3. Pten deletion in endoderm affects ERK and AKT phosphorylation
Both ERK and AKT pathways have been reported to be regu-
lated by Pten (Vivanco and Sawyers, 2002; Xing et al., 2010). Ac-
tivation of ERK kinase 1/2 positively regulated airway epithelial
cell migration in vitro (Enomoto et al., 2005). AKT is also well
known as an important regulator of cell survival, growth and cell
migration in various organs. To determine the mechanisms of
Pten-regulated endodermal morphogenesis, we analyzed the le-
vels of activated (phospho) ERK and AKT in developing lungs. By
western-blot analysis, we found that activation (phosphorylation)
of ERK and AKT was reduced in PtenΔ/Δ lung during the windowFig. 3. The expression patterns of phospho-ERK and phospho-AKT in PtenΔ/Δ lungs. Pan
reduced in E12.5 PtenΔ/Δ lungs but it is increased in E18.5 PtenΔ/Δ lungs. Panel B: In consist
endodermal explants.(E12.5) in which defects in branching were observed (Fig. 3, Panel
A; Fig. 1, Panel C). The reductions of phospho-ERK and phospho-
AKT levels were also conﬁrmed in PtenΔ/Δ lung explants (Fig. 3,
Panel B). Importantly, phospho-ERK and phospho-AKT levels were
increased in E18.5 PtenΔ/Δ lungs compared to controls (Fig. 3, Panel
A).
3.4. The role of phospho-ERK in branching morphogenesis
As decrease of phospho-ERK and phospho-AKT in the mutant
lungs occurred only during the early stage when branching mor-
phogenesis was affected, we hypothesized that this reduction in
E12.5 lungs may be responsible for the defect in branching mor-
phogenesis (Fig. 1, g). To test this hypothesis we generated mice
with over-expression of a dominant negative MEK1 (dnMEK1) via
deletion of a stop cassette through the activity of Gata5-Cre (Fig. 4,
Panel A). By western-blot analysis, we conﬁrmed that the level of
phospho-ERK was signiﬁcantly reduced in mutant lungs (Fig. 4,
Panel B). On day E12.5, the MEKDN/þ; Gata5-Cre lungs were much
smaller and showed less branching (Fig. 4, Panel C). However, the
airway epithelium in the mutant lungs appeared multilayered
compared to controls. To examine whether reduced ERK activation
affected cell proliferation or cell death, anti-Ki67 and TUNEL
staining were employed. Interestingly, there was no signiﬁcant
difference found between mutant and control lungs (Supple-
mental Fig. 1). By quantitative PCR analysis, RhoA, Rac1 and Cdc42
were signiﬁcantly decreased in E12.5MEKDN/þ ; Gata5-Cre lung as
compared to control lungs (Fig. 4, Panel D). These data suggested
that the observed branching morphogenesis defects in MEKDN/þ;
Gata5-Cre lungs might be caused by reduced cell migration,
without discernible or measurable changes in cell proliferation or
apoptosis. Consistent with the in vivo data, the mesenchyme-free
endodermal explants from MEKDN/þ ; Gata5-Cre lung exhibited
signiﬁcant reduction in branching morphogenesis after 48 h of
FGF10 treatment in vitro (Fig. 5, Panel A). In addition, BrdU ana-
lysis, revealed no differences in the ratios of BrdU positive cells to
total cell counts between mutant and control explants (Fig. 5,
Panel B). To further analyze the impact of phospho-ERK on lung
morphogenesis, we used embryonic whole lung explants. E11.5
embryonic mouse lungs were excised from mouse embryos and
cultured in a serum-free medium (Xing et al., 2008) in presence or
absence of 4ng/ml MEK inhibitor. The result showed MEK inhibitor
had a profound inhibitory impact on branching morphogenesisel A: Comparing with control lungs, the level of ERK and AKT phosphorylations is
ent with in vivo data, the level of ERK and AKT phosphorylation is reduced in PtenΔ/Δ
Fig. 4. Generation ofMEKDN/þ ; Gata5-cremice. MEKDN/þ ; Gata5-Cremice were generated by crossingMEKDN/þ mice with Gata5-Cremice (Panel A). By western blot analysis,
the level of ERK phosphorylation was dramatically reduced in MEKDN/þ ; Gata5-Cre mice (Panel B). Panel C: On day E12.5, MEKDN/þ ; Gata5-Cre lungs appeared smaller in
overall size and less branching, although the thickness of epithelial airway appears different. Panel D: By real-time PCR analysis, the expression of RhoA, Rac1 and Cdc42 is
reduced largely in E12.5 PtenΔ/Δ lungs.
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Panel D).
To determine whether phospho-ERK mediates embryonic lung
branching morphogenesis via regulating cell migration, we con-
ducted the following two experiments. First, in mesenchyme-free
endoderm culture experiments, both mutant and control en-
doderm explants were treated with directional FGF10 signaling as
described earlier. As expected, the control explants showed che-
motaxis in the direction of FGF10 within 18 h of treatment. In
contrast, chemotaxis was blocked in mutant explants (Fig. 6, Panel
A). Secondly, monolayers of isolated epithelial cells from me-
senchyme-free explants were wounded to test cell migration. After
12 h, cells from control explants had undergone a 66% wound
closure. In contrast, cells from MEK inhibitor treated cells showed
only a mere 20% wound closure (Fig. 6. Panel B and C).
3.5. The role of phospho-AKT in branching morphogenesis
We also generated R26StopFL-Pik3ca; Gata5-Cre (referred to
here as P110ﬂ/ﬂ; Gata5-Cre) mice to over-express P110. P110 is a
constitutively active form of the mouse catalytic P110α subunit of
PI3K (Srinivasan et al., 2009). Interestingly, phosphorylation of
AKT was completely blocked in P110ﬂ/ﬂ; Gata5-Cre lungs (Fig. 7.
Panel A&B). This made the P110ﬂ/ﬂ; Gata5-Cre a perfect model to
examine the impact of phospho-AKT on branching morphogenesis.
Compared with the controls, Phospho-AKT-deﬁcient P110ﬂ/ﬂ;
Gata5-cre mice appeared normal in overall size and airway
branching at E12.5 (Fig. 7. Panel C). In mesenchyme-free explants
culture, the mutant explants displayed normal branching mor-
phogenesis (Fig. 7. Panel D). Both mutant and control explants
showed clear chemotaxis in the direction of FGF10 beads (Fig. 7.
Panel E). By real-time PCR analysis, there was no signiﬁcantchange detected in the expression of RhoA, Rac1 and Cdc42 be-
tween P110ﬂ/ﬂ; Gata5-Cre lungs and controls (Fig. 7, Panel F).4. Discussion
The purpose of the current study was to determine the precise
role of endodermal-speciﬁc Pten in early lung branching mor-
phogenesis. Endodermal deletion of Pten disrupted branching
morphogenesis during early stage of lung development (between
E11.5 and E13.5). Both in vivo, ex vivo, and cell culture experiments
demonstrated that the inhibition of branching by Pten deletion is
due to inhibition of cell migration, without measurable changes in
cell proliferation. Since inhibition of branching morphogenesis
was concomitant with changes in expression of phosphor-ERK and
AKT, we therefore examined the roles of the latter molecules in
embryonic lung branching and in airway epithelial cell migration.
Examination of conditional deletion of phospho-ERK and AKT
found that only phospho-ERK is required for cell migration and
branching morphogenesis, but not phospho-AKT (Fig. 8).
In this study, our ﬁrst aim was to determine whether Pten loss-
of-function in epithelial cell impacts lung morphogenesis during
development. Loss-of-function of Pten has been found in a wide
range of human tumors (Ali et al., 1999). Various mouse models
were generated to study the crucial role of Pten as tumor sup-
pressor. Pten knock-out mice die early in development, but the
cellular and developmental bases of lethality have not been de-
ﬁned. In recent years, several mouse models of epithelial-speciﬁc
inactivation of Pten were made to study the roles of Pten during
lung development. Surprisingly, the results from different research
groups drove to different conclusions. By using SPC-rtTA/(tetO)7
-Cre/Ptenﬂ/ﬂ mice model, Yanagi showed that Pten was essential for
Fig. 5. Reduction of ERK phosphorylation blocks branching morphogenesis. Panel A: Endodermal explants from E12.5 control and MEKDN/þ ; Gata5-Cre lungs are cultured in
presence of FGF10. After 48 h, the control explants undergo robust morphogenesis (a and c). Whereas MEKDN/þ ; Gata5-Cre explants shows reduction of branching (b&d).
Panel B: By BrdU analysis, the ratio of proliferating cells in total cells shows no difference between control and MEKDN/þ ; Gata5-Cre explants, P¼0.31. Panel C: Lungs from
E12.5 mice are cultured and treated with MEK inhibitor vs DMSO as control. After 48 h, the control lung undergoes branching morphogenesis (a and c). Whereas MEK
inhibitor-treated lung shows signiﬁcant reduction in branching (b and d). Panel D: Western-blot result shows that MEK inhibitor can fully block ERK phosphorylation in
treated lung.
Fig. 6. Deletion of ERK phosphorylation reduces cell migration. Panel A: Endodermal explants from both control and MEKDN/þ ; Gata5-Cre lungs were treated with FGF10-
soaked beads. The control explants move towards FGF10 source after 8 h culture. In opposite, MEKDN/þ ; Gata5-Cre explants show no sign of movement. Panel B: Epithelial
cells from E12.5 lungs were cultured and wounded. After 12 h, the control cells show 66% wound healing, where as MEK inhibitor treated cells show 20% (Panel C).
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Fig. 7. Reduction of AKT phosphorylation does not affect lung morphogenesis and cell migration. Panel A: Generation of P110ﬂ/ﬂ; Gata5-cremice. Panel B: Western-blot result
shows that phospho-AKT is signiﬁcantly reduced in P110ﬂ/ﬂ; Gata5-Cre lung. Panel C: On day E12.5, P110ﬂ/ﬂ; Gata5-Cre lung shows no defects in overall size and branching
morphogenesis. Panel D: In mesenchyme-free explants culture, P110ﬂ/ﬂ; Gata5-Cre explants undergo budding as control explants after treated with FGF10. Both mutant and
control explants show clear chemotaxis in the direction of the FGF10 beads (Panel E). Panel F: Comparing with control lungs, the lungs from E12.5 P110ﬂ/ﬂ; Gata5-Cre show no
difference in RhoA, Rac1 and Cdc42 expressions.
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observed in E18 lung by Yanagi did not seem to occur in Dave's
mice (Davé et al., 2008). Comparing with their model, in our case,
Gata5-Cre targets lung epithelial progenitors much early than SPC-
rtTA/(tetO)7Cre. This allows us to see changes in early stage of
lung development. In this paper, by generating Ptenﬂ/ﬂ; Gata5-Cre
mice, we found that Pten is required for early lung branching
morphogenesis by inhibiting cell migration. Interestingly, this af-
fection was time-dependent and rescued in later embryonic stage.
Prior to the current study, the roles of Pten in regulating cell mi-
gration were very different depending on the experimental ma-
terials used. Several reports showed that loss of Pten in developing
tissues, such as neutrophils and B cells (Anzelon et al., 2003; Heit
et al., 2008), disrupted cell migration and the ability to respond to
chemoattractants. However, the studies from human cancer cell
lines showed opposite results (Raftopoulou et al., 2004; Leslieet al., 2005), the cells lacking Pten migrated faster. Together with
our data, it suggests that the function of Pten in cell migration is
dependent on the cellular context. During lung development,
E12.5 and E18.5 represent two distinct developmental stages, the
pseudoglandular and saccular stages, respectively. At E12.5, lung
epithelial cells remain as progenitors, while at E18.5 lung epithe-
lial cells have differentiated into multiple cell types which have
distinct gene expression proﬁles. These intrinsic differences may
underlie the stage dependent role of Pten in cell migration. Pre-
vious studies showed that mechanisms by the C2 domain of Pten
and the autodephosphorylation of Pten mediate cell migration.
These two mechanisms are both involved in phosphatase activity
which can alter cell migration (Raftopoulou et al., 2004). In our
case, whether the two mechanisms caused the differences be-
tween E12.5 and E18.5 Pten null epithelial cells is unknown.
Our second aim was to investigate which downstream target
Fig. 8. A simpliﬁed model illustrating Pten signaling in early lung branching
morphogenesis. In E12.5 lung, Pten positively regulates ERK and AKT phosphor-
ylation. The Pten-ERK pathway controls airway branching via regulation of epi-
thelial cell migration, without measurable alterations in cell proliferation. The Pten-
AKT pathway does not appear to affect epithelial cell migration.
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regulated cell migration. By western blot analyses, we found de-
letion of PTEN results in decreased levels of phospho-ERK (Fig. 3)
in airway epithelial cells during early stage of lung development.
Previous studies have demonstrated that the MEK/ERK cascade
mediates FGF signaling (Kuslak and Marker, 2007), which func-
tions as the major chemoattractants on the branching epithelium
(Weaver et al., 2000). These data collectively suggest a central role
of MEK/ERK pathway in epithelial cell migration. We therefore
generated theMEKDM/þ ; Gata5-Cremice to conditionally inactivate
the MEK/ERK pathway in embryonic lung epithelial cells. Ex-
amination of lung morphogenesis and epithelial cell migration in
phospho-ERK mutant lungs revealed a marked reduction in
number of branching and speed of cell movement. This study, for
the ﬁrst time, directly demonstrated the critical roles of MEK/ERK
pathway in lung branching morphogenesis and in lung epithelial
cell migration. In the PTEN mutant lung, deletion of PTEN de-
creases levels of phospho-ERK which is essential for mediating the
chemotactic effectors of FGF10 on the branching epithelium.
To date, it is still poorly understood how the ERK signaling
pathway is involved in cell migration. In current study, we found
that the decreased phospho-ERK level lead to reduction of Cdc42,
Rac1 and RhoA in early lung embryonic epithelial cells. But the
regulations or collaborations between MEK/ERK pathway and Rho
family GTPases are still not clear. Previous published data in hu-
man skin ﬁbroblasts showed that Cdc42 downregulates MMP-1
expression by inhibiting the ERK pathway (Deroanne et al., 2005).
In transformed cells, ERK kinase selectively uncouples RhoA from
one of its effecter pathways (Sahai et al., 2001). Other recent study
also indicated that the architecture of the Rho kinase–ERK net-
work allows bi-directional ﬂow of information in its default state
to regulate neuronal differentiation (Hensel et al., 2013). In our
case, it needs further investigation to discover whether ERK
regulated Rho family GTPases expression is direct interaction.The ERK activity is stimulated by a wide variety of growth
factors and mitogens (Huang et al., 2004). In PtenΔ/Δ lungs, levels
of phospho-ERK is decreased in early stage but increased in late
stages of lung development. The stage dependent ERK activity in
Pten deﬁcient lungs might be caused by interactions of Pten with
other pathways that also regulate ERK cascade. For example, our
previous results showed that TGFß/ALK5 signaling controls ERK
phosphorylation, and this is negatively regulated by PTEN in E18.5
lung epithelial (Xing et al., 2010). Therefore, the balance between
Pten and TGFß/ALK5 signaling (and other ERK regulators such as
FGF10) may modify the overall ERK activity at different develop-
mental stages. An activity proﬁle of all the ERK regulators at each
embryonic stage may provide a more detail explanation on the
stage dependent ERK activity in PtenΔ/Δ lungs. Nevertheless, cur-
rent study demonstrated that ERK activity is critical for epithelial
cell migration during embryonic lung development.
To investigate whether the level of phospho-AKT affects lung
morphogenesis and epithelial cell migration, we generated P110ﬂ/ﬂ;
Gata5-Cre mouse, which constitutively active p110α. Western-blot
result showed that the level of phospho-AKT in mutant lung is
signiﬁcantly reduced (Fig. 7, Panel B). By in vivo and in vitro ex-
amination, the reduction of phospho-AKT level does not affect
early airway branching and the speed of epithelial cell movement.
This result suggests that, contrary to the prevailing concept, Pten-
regulated cell migration is mediated by PI3K/AKT-independent
pathway in embryonic lung epithelial cells. Previous studies found
that many of Pten's cellular processes are through PI3K signaling.
PI3Ks are classiﬁed into three groups (class I, II and III) based on
structure and substrate speciﬁcity (Engelman et al., 2006). Class IA
PI3Ks transduce signals encoding its catalytic subunit p110α,
which is the only PI3K gene identiﬁed with common mutations in
human cancer (Engelman et al., 2006). Activated PI3Ks catalyze
the formation of PIP3 from PIP2, and PTEN directly opposes the
activity of PI3Ks by dephosphorylating PIP3 into PIP2. AKT is a
centrally important downstream effector of PIP3. We have showed
that the expression of p110 was largely increased in mutant lung.
Surprisingly, the level of phospho-AKT in mutant lung was sig-
niﬁcantly reduced. As suggested by a review from Chalhoub and
Baker (2009), the PI3K signaling pathway is more complex in
mammals due to the evolution of multiple family members for
some effectors in the pathway and also the diversity of growth
factors that transmit their signals through PI3K in context-de-
pendent fashions. It is possible that the AKT phosphorylation is
directly blocked by other factors from cross-talk pathways in
mutant lung, although increased p110 may cause higher level of
PIP3. It still needs further investigation to discover whether this
potential signaling transition is selectively expressed in lung epi-
thelial cells. Nevertheless, epithelial speciﬁc reduction of phospho-
AKT in P110ﬂ/ﬂ; Gata5-Cre lungs does not appear to disrupt early
lung morphogenesis. A recent study by Carter et al. (2014) showed
that airway branching is increased in lung explants, in which AKT
activity is globally blocked by pharmacological inhibitor. These
indicate that the AKT activity in the mesenchymal compartment
may also contribute to regulating airway branching. The me-
senchymal compartment is the major source of chemotatic factors
for airway branching.
A wealth of knowledge regarding Pten regulated cell migration
has come from both development and cancer. Pten deletion in the
developing nervous system shows the failure of neurons to com-
plete migration (Kwon et al., 2001). Whereas overexpression of
Pten can inhibit glioma cell migration (Raftopoulou et al., 2004).
Thus, both Pten loss and gain of function can inhibit migration in
different setting. It was generally thought that Pten-regulated cell
migration was through PI3K pathway. Interestingly, strong evi-
dence now indicates that the principal mechanism by which
Pten expression inhibits cell migration is PI3K-independent, and
Y. Xing et al. / Developmental Biology 408 (2015) 56–65 65mediated through C2 domain of Pten (Raftopoulou et al., 2004). In
present study, we have found Pten regulated lung epithelial cell
migration is PI3K-pathway independent. Since, this effect is cor-
rected in later stage; it is unlikely that the blocking of cell mi-
gration in early branching morphogenesis is mediated through C2
domain of Pten.Acknowledgments
This work was supported by NIH/NHLBI (HL075334, HL060231,
HL071945, HL089445, and HL062569), the Project for Extramural
Scientists of State Key Laboratory of Agrobiotechnology and
generous funds from China Agricultural University, China
(2015SKLAB6-5).Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2015.10.002.References
Ali, I.U., Schriml, L.M., Dean, M., 1999. Mutational spectra of PTEN/MMAC1 gene: a
tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst. 91 (22),
1922–1932 17.
Anzelon, A.N., Wu, H., Rickert, R.C., 2003. Pten inactivation alters peripheral B
lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4 (3),
287–294.
Bellusci, S., Grindley, J., Emoto, H., Itoh, N., Hogan, B.L., 1997. Fibroblast growth
factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung.
Development. 124 (23), 4867–4878.
Carter, E., Miron-Buchacra, G., Goldoni, S., Danahay, H., Westwick, J., Watson, M.L.,
Tosh, D., Ward, S.G., 2014. Phosphoinositide 3-kinase alpha-dependent reg-
ulation of branching morphogenesis in murine embryonic lung: evidence for a
role in determining morphogenic properties of FGF7. PLoS One 9 (12).
Chalhoub, N., Baker, S.J., 2009. PTEN and the PI3-kinase pathway in cancer. Annu.
Rev. Pathol. 4, 127–150.
Corti, M., Brody, A.R., Harrison, J., 1996. Isolation and primary culture of murine
alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14, 309–315.
Di Cristofano, A., Pesce, B., Cordon-Cardo, C., Pandolﬁ, P.P., 1998. Pten is essential for
embryonic development and tumour suppression. Nat. Genet. 19 (4), 348–355.
Davé, V., Wert, S.E., Tanner, T., Thitoff, A.R., Loudy, D.E., Whitsett, J.A., 2008. Con-
ditional deletion of Pten causes bronchiolar hyperplasia. Am. J. Respir. Cell Mol.
Biol. 38 (3), 337–345.
Deroanne, C.F.1, Hamelryckx, D., Ho, T.T., Lambert, C.A., Catroux, P., Lapière, C.M.,
Nusgens, B.V., 2005. Cdc42 downregulates MMP-1 expression by inhibiting the
ERK1/2 pathway. J. Cell Sci. 118 (Pt 6), 1173–1183 15.
Engelman, J.A., Luo, J., Cantley, L.C., 2006. The evolution of phosphatidylinositol
3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7 (8),
606–619.
Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., Mur-
akumo, Y., Usukura, J., Kaibuchi, K., Takahashi, M., 2005. Akt/PKB regulates actinorganization and cell motility via Girdin/APE. Dev. Cell 9 (3), 389–402.
Heit, B., Robbins, S.M., Downey, C.M., Guan, Z., Colarusso, P., Miller, B.J., Jirik, F.R.,
Kubes, P., 2008. PTEN functions to’‘prioritize’ chemotactic cues and pre-
vent’‘distraction’ in migrating neutrophils. Nat. Immunol. 9 (7), 743–752.
Hensel, N., Stockbrügger, I., Rademacher, S., Broughton, N., Brinkmann, H., Grothe,
C., Claus, P., 2013. Bilateral crosstalk of rho- and extracellular-signal-regulated-
kinase (ERK) pathways is conﬁned to an unidirectional mode in spinal muscular
atrophy (SMA). Cell Signal. 26 (3), 540–548. http://dx.doi.org/10.1016/j.cell-
sig.2013.11.027, Dec 3.
Huang, C., Jacobson, K., Schaller, M.D., 2004. MAP kinases and cell migration. J. Cell
Sci. 117 (Pt 20), 4619–4628 15.
Iden, S.1, Collard, J.G., 2008. Crosstalk between small GTPases and polarity proteins
in cell polarization. Nat. Rev. Mol. Cell Biol. 9 (11), 846–859. http://dx.doi.org/
10.1038/nrm2521.
Klemke, R.L.1, Cai, S., Giannini, A.L., Gallagher, P.J., de Lanerolle, P., Cheresh, D.A.,
1997. Regulation of cell motility by mitogen-activated protein kinase. J. Cell
Biol. 137 (2), 481–492.
Kuslak, S.L., Marker, P.C., 2007. Fibroblast growth factor receptor signaling through
MEK-ERK is required for prostate bud induction. Differentiation. 75 (7),
638–651.
Kwon, C.H., Zhu, X., Zhang, J., Knoop, L.L., Tharp, R., Smeyne, R.J., Eberhart, C.G.,
Burger, P.C., Baker, S.J., 2001. Pten regulates neuronal soma size: a mouse model
of Lhermitte–Duclos disease. Nat. Genet. 29 (4), 404–411.
Leslie, N.R., Yang, X., Downes, C.P., Weijer, C.J., 2005. The regulation of cell migration
by PTEN. Biochem. Soc. Trans. 33 (Pt 6), 1507–1508.
Li, T.F., O’Keefe, R.J., Chen, D., 2005. TGF-beta signaling in chondrocytes. Front.
Biosci. 1 (10), 681–688.
Machacek, M., Hodgson, L., Welch, C., Elliott, H., Pertz, O., Nalbant, P., Abell, A.,
Johnson, G.L., Hahn, K.M., Danuser, G., 2009. Coordination of Rho GTPase ac-
tivities during cell protrusion. Nature 461 (7260), 99–103 3.
McKay, M.M., Morrison, D.K., 2007. Integrating signals from RTKs to ERK/MAPK.
Oncogene. 26 (22), 3113–3121 14.
Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S., Hall, A., 2004. Reg-
ulation of cell migration by the C2 domain of the tumor suppressor PTEN.
Science 303 (5661), 1179–1181 20.
Sahai, E., Olson, M.F., Marshall, C.J., 2001. Cross-talk between Ras and Rho signalling
pathways in transformation favours proliferation and increased motility. EMBO
J. 20 (4), 755–766 15.
Sanges, D., Cosma, M.P., 2010. Reprogramming cell fate to pluripotency: the deci-
sion-making signalling pathways. Int. J. Dev. Biol. 54 (11-12), 1575–1587. http:
//dx.doi.org/10.1387/ijdb.103190ds, Review.
Srinivasan, L., Sasaki, Y., Calado, D.P., Zhang, B., Paik, J.H., DePinho, R.A., Kutok, J.L.,
Kearney, J.F., Otipoby, K.L., Rajewsky, K., 2009. PI3 kinase signals BCR-depen-
dent mature B cell survival. Cell 139 (3), 573–586.
Stiles, B., Groszer, M., Wang, S., Jiao, J., Wu, H., 2004. PTENless means more. Dev.
Biol. 273 (2), 175–184 15.
Vivanco, I., Sawyers, C.L., 2002. The phosphatidylinositol 3-Kinase AKT pathway in
human cancer. Nat. Rev. Cancer 2 (7), 489–501.
Weaver, M., Dunn, N.R., Hogan, B.L., 2000. Bmp4 and Fgf10 play opposing roles
during lung bud morphogenesis. Development 127 (12), 2695–2704.
Xing, Y., Li, C., Hu, L., Tiozzo, C., Li, M., Chai, Y., Bellusci, S., Anderson, S., Minoo, P.,
2008. Mechanisms of TGFbeta inhibition of LUNG endodermal morphogenesis:
the role of TbetaRII, Smads, Nkx2.1 and Pten. Dev. Biol. 320 (2), 340–350.
Xing, Y., Li, C., Li, A., Sridurongrit, S., Tiozzo, C., Bellusci, S., Borok, Z., Kaartinen, V.,
Minoo, P., 2010. Signaling via Alk5 controls the ontogeny of lung Clara cells.
Development. 137 (5), 825–833.
Yanagi, S., Kishimoto, H., Kawahara, K., Sasaki, T., Sasaki, M., Nishio, M., Yajima, N.,
Hamada, K., Horie, Y., Kubo, H., Whitsett, J.A., Mak, T.W., Nakano, T., Nakazato,
M., Suzuki, A., 2007. Pten controls lung morphogenesis, bronchioalveolar stem
cells, and onset of lung adenocarcinomas in mice. J. Clin. Investig. 117 (10),
2929–2940.
